Table 4 Univariate predictors of death in patients with confirmed Influenza A H1N1 infection (n = 157)
From: Evaluation of Influenza A H1N1 infection and antiviral utilization in a tertiary care hospital
Variable | Discharge (n = 149) | Death (n = 8) | OR (95% CI) | P value |
|---|---|---|---|---|
Male gender | 79 (53.0) | 6 (75.0) | 2.66 (0.59; 18.55) | 0.240 |
Age (> 60 years old) | 35 (23.5) | 2 (25.0) | 1.09 (0.15; 4.96) | 0.922 |
Immunocompromised status | 13 (8.7) | 3 (37.5) | 6.28 (1.18; 28.72) | 0.019 |
Diabetes mellitus | 25 (16.8) | 3 (37.5) | 2.98 (0.58; 12.94) | 0.153 |
Kidney disease | 9 (6.0) | 2 (25.0) | 5.19 (0.69; 26.60) | 0.063 |
Cardiovascular disease | 50 (33.6) | 4 (50.0) | 1.98 (0.45; 8.69) | 0.348 |
Hospitalization characteristics | ||||
Vasoactive drugs | 14 (9.4) | 6 (75.0) | 28.93 (6.04; 210.94) | < 0.001 |
Mechanical ventilation | 12 (8.1) | 5 (62.5) | 19.03 (4.18; 102.52) | < 0.001 |
Acute hemodialysis | 6 (4.0) | 2 (25.0) | 7.94 (1.02; 44.30) | 0.024 |
Surgical procedure | 10 (6.7) | 5 (62.5) | 23.17 (5.00; 127.25) | < 0.001 |
Thoracic surgery | 3 (2.0) | 3 (37.5) | 29.20 (4.49; 199.40) | < 0.001 |
Albumin administration | 17 (11.4) | 6 (75.0) | 23.29 (4.93; 168.04) | < 0.001 |
Length of stay (days) | 5 [3, 7] | 38 [11.5, 53.75] | 1.07 (1.03; 1.11) | < 0.001 |